BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1347147)

  • 1. Isoproterenol-initiated beta-adrenergic receptor diacytosis in cultured cells.
    Kurz JB; Perkins JP
    Mol Pharmacol; 1992 Feb; 41(2):375-81. PubMed ID: 1347147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (-)-[125I]-iodopindolol, a new highly selective radioiodinated beta-adrenergic receptor antagonist: measurement of beta-receptors on intact rat astrocytoma cells.
    Barovsky K; Brooker G
    J Cyclic Nucleotide Res; 1980; 6(4):297-307. PubMed ID: 6110683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Turnover of beta 1- and beta 2-adrenergic receptors after down-regulation or irreversible blockade.
    Neve KA; Molinoff PB
    Mol Pharmacol; 1986 Aug; 30(2):104-11. PubMed ID: 3016496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of binding of 125I-iodopindolol to control and desensitized cells at 37 degrees and on ice.
    Toews ML; Waldo GL; Harden TK; Perkins JP
    J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(1):47-62. PubMed ID: 3009571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of agonists and antagonists with beta-adrenergic receptors on intact L6 muscle cells.
    Pittman RN; Molinoff PB
    J Cyclic Nucleotide Res; 1980; 6(6):421-35. PubMed ID: 6260844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptors for beta-adrenergic agonists in cultured chick ventricular cells. Relationship between agonist binding and physiologic effect.
    Marsh JD; Smith TW
    Mol Pharmacol; 1985 Jan; 27(1):10-8. PubMed ID: 2981398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a density shift method to assess beta-adrenergic receptor synthesis during recovery from catecholamine-induced down-regulation in human astrocytoma cells.
    Waldo GL; Doss RC; Perkins JP; Harden TK
    Mol Pharmacol; 1984 Nov; 26(3):424-9. PubMed ID: 6092895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a bromoacetylated derivative of pindolol as a high affinity, irreversible beta adrenergic antagonist in cultured cells.
    Jasper JR; Motulsky HJ; Insel PA
    J Pharmacol Exp Ther; 1988 Mar; 244(3):820-4. PubMed ID: 2908047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [125I]iodopindolol: a new beta adrenergic receptor probe.
    Ezrailson EG; Garber AJ; Munson PJ; Swartz TL; Birnbaumer L; Entman ML
    J Cyclic Nucleotide Res; 1981; 7(1):13-26. PubMed ID: 6265511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of antimycin A on endocytosis and exocytosis of transferrin also are observed for internalization and externalization of beta-adrenergic receptors.
    Liao JF; Perkins JP
    Mol Pharmacol; 1993 Aug; 44(2):364-70. PubMed ID: 8394993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective regulation of beta-1 and beta-2 adrenergic receptors by atypical agonists.
    Neve KA; Barrett DA; Molinoff PB
    J Pharmacol Exp Ther; 1985 Dec; 235(3):657-64. PubMed ID: 2867205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta adrenergic receptor repopulation of C6 glioma cells after irreversible blockade and down regulation.
    Homburger V; Pantaloni C; Lucas M; Gozlan H; Bockaert J
    J Cell Physiol; 1984 Dec; 121(3):589-97. PubMed ID: 6094600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonist-induced changes in the properties of beta-adrenergic receptors on intact S49 lymphoma cells. Time-dependent changes in the affinity of the receptor for agonists.
    Hoyer D; Reynolds EE; Molinoff PB
    Mol Pharmacol; 1984 Mar; 25(2):209-18. PubMed ID: 6142414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intact cell binding properties of cells expressing altered beta-adrenergic receptors.
    Zhu SJ; Toews ML
    Mol Pharmacol; 1994 Feb; 45(2):255-61. PubMed ID: 7906855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of full and partial agonists with beta-adrenergic receptors on intact L6 muscle cells.
    Pittman RN; Molinoff PB
    Mol Pharmacol; 1983 Nov; 24(3):398-408. PubMed ID: 6138704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of beta-adrenergic receptors in synchronous and asynchronous S49 lymphoma cells. I. Receptor metabolism after irreversible blockade of receptors and in cells traversing the cell division cycle.
    Mahan LC; Insel PA
    Mol Pharmacol; 1986 Jan; 29(1):7-15. PubMed ID: 2868411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered adrenergic response and specificity of the receptors in rat ascites hepatoma AH130.
    Sanae F; Miyamoto K; Koshiura R
    Cancer Res; 1989 Nov; 49(22):6242-6. PubMed ID: 2553251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta 1- and beta 2-adrenergic receptors display subtype-selective coupling to Gs.
    Green SA; Holt BD; Liggett SB
    Mol Pharmacol; 1992 May; 41(5):889-93. PubMed ID: 1350321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in endosomal targeting of human (beta)1- and (beta)2-adrenergic receptors following clathrin-mediated endocytosis.
    Liang W; Curran PK; Hoang Q; Moreland RT; Fishman PH
    J Cell Sci; 2004 Feb; 117(Pt 5):723-34. PubMed ID: 14734649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist-induced changes in beta-adrenergic receptors on intact cells.
    Toews ML; Perkins JP
    J Biol Chem; 1984 Feb; 259(4):2227-35. PubMed ID: 6142040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.